• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C9orf72 扩展在亨廷顿病表型模拟队列中的临床谱。

Clinical spectrum of C9orf72 expansion in a cohort of Huntington's disease phenocopies.

机构信息

Neurology Department, Centro Hospitalar do Porto, Largo do Professor Abel Salazar, 4099-001, Porto, Portugal.

Neuroradiology Department, Centro Hospitalar do Porto, Porto, Portugal.

出版信息

Neurol Sci. 2018 Apr;39(4):741-744. doi: 10.1007/s10072-018-3268-7. Epub 2018 Feb 13.

DOI:10.1007/s10072-018-3268-7
PMID:29441485
Abstract

The expansion in the C9orf72 gene has been recently reported as a genetic cause of Huntington's disease (HD) phenocopies. We aim to assess the frequency of the C9orf72 gene expansion in a Portuguese HD phenocopies cohort. Twenty HD phenotype-like patients without diagnosis were identified in our institutional database. C9orf72 gene expansion was detected using repeat-primed PCR. Clinical files were reviewed to characterize the phenotype of expansion-positive cases. One patient (5%) was positive for the C9orf72 expansion. A second patient presented 27 repeats-within the intermediate size interval. Both had familial neuropsychiatric disease characterized by diverse movement disorders, dementia, and psychiatric dysfunction that was distinct in severity and clinical expression. C9orf72 disease is clinically heterogeneous and without evident imaging markers. The definition of the role of intermediate alleles and of the pathological threshold for C9orf72 repeat expansions may have diagnostic implications.

摘要

C9orf72 基因扩增最近被报道为亨廷顿病(HD)表型副本的遗传原因。我们旨在评估葡萄牙 HD 表型副本队列中 C9orf72 基因扩增的频率。在我们的机构数据库中确定了 20 名具有 HD 表型的无诊断患者。使用重复引物 PCR 检测 C9orf72 基因扩增。回顾临床档案以表征扩增阳性病例的表型。一名患者(5%)的 C9orf72 扩增呈阳性。第二名患者的重复次数在中间大小间隔内为 27 次。两者均具有家族性神经精神疾病,其特征是运动障碍、痴呆和精神功能障碍多种多样,严重程度和临床表现明显不同。C9orf72 疾病的临床表现具有异质性,没有明显的影像学标志物。中间等位基因的作用和 C9orf72 重复扩增的病理阈值的定义可能具有诊断意义。

相似文献

1
Clinical spectrum of C9orf72 expansion in a cohort of Huntington's disease phenocopies.C9orf72 扩展在亨廷顿病表型模拟队列中的临床谱。
Neurol Sci. 2018 Apr;39(4):741-744. doi: 10.1007/s10072-018-3268-7. Epub 2018 Feb 13.
2
C9orf72 Repeat Expansion Frequency among Patients with Huntington Disease Genetic Testing.C9orf72 重复扩展频率在亨廷顿病基因检测患者中的研究。
Neurodegener Dis. 2018;18(5-6):239-253. doi: 10.1159/000492499. Epub 2018 Oct 18.
3
C9ORF72 hexanucleotide repeat expansions are a frequent cause of Huntington disease phenocopies in the Greek population.C9ORF72六核苷酸重复扩增是希腊人群中亨廷顿病表型模拟的常见原因。
Neurobiol Aging. 2015 Jan;36(1):547.e13-6. doi: 10.1016/j.neurobiolaging.2014.08.020. Epub 2014 Aug 27.
4
C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies.C9orf72 扩增是亨廷顿病表型模拟最常见的遗传原因。
Neurology. 2014 Jan 28;82(4):292-9. doi: 10.1212/WNL.0000000000000061. Epub 2013 Dec 20.
5
Screening for the C9ORF72 repeat expansion in a greek frontotemporal dementia cohort.希腊额颞叶痴呆队列中C9ORF72重复扩增的筛查。
Amyotroph Lateral Scler Frontotemporal Degener. 2018 Feb;19(1-2):152-154. doi: 10.1080/21678421.2017.1400070. Epub 2017 Nov 23.
6
The association between repeat number in C9orf72 and phenotypic variability in Turkish patients with frontotemporal lobar degeneration.C9orf72 重复次数与土耳其额颞叶变性患者表型变异性之间的关联。
Neurobiol Aging. 2019 Apr;76:216.e1-216.e7. doi: 10.1016/j.neurobiolaging.2018.12.007. Epub 2018 Dec 28.
7
Genetic screening for Huntington disease phenocopies in Sweden: A tertiary center case series focused on short tandem repeat (STR) disorders.瑞典亨廷顿病表型模拟的遗传筛查:以短串联重复 (STR) 疾病为重点的三级中心病例系列。
J Neurol Sci. 2023 Aug 15;451:120707. doi: 10.1016/j.jns.2023.120707. Epub 2023 Jun 10.
8
ATXN1 intermediate-length polyglutamine expansions are associated with amyotrophic lateral sclerosis.ATXN1 中长段聚谷氨酰胺扩展与肌萎缩侧索硬化症有关。
Neurobiol Aging. 2018 Apr;64:157.e1-157.e5. doi: 10.1016/j.neurobiolaging.2017.11.011. Epub 2017 Nov 28.
9
Phenotypic variability and neuropsychological findings associated with C9orf72 repeat expansions in a Bulgarian dementia cohort.在一个保加利亚痴呆队列中与 C9orf72 重复扩展相关的表型变异性和神经心理学发现。
PLoS One. 2018 Dec 14;13(12):e0208383. doi: 10.1371/journal.pone.0208383. eCollection 2018.
10
C9orf72 hexanucleotide repeat expansions and Ataxin 2 intermediate length repeat expansions in Indian patients with amyotrophic lateral sclerosis.印度肌萎缩侧索硬化症患者中C9orf72六核苷酸重复序列扩增和共济失调蛋白2中间长度重复序列扩增
Neurobiol Aging. 2017 Aug;56:211.e9-211.e14. doi: 10.1016/j.neurobiolaging.2017.04.011. Epub 2017 Apr 26.

引用本文的文献

1
Unravelling the clinical spectrum and the role of repeat length in repeat expansions.解析重复扩展的临床谱及其重复长度的作用。
J Neurol Neurosurg Psychiatry. 2021 May;92(5):502-509. doi: 10.1136/jnnp-2020-325377. Epub 2021 Jan 15.
2
Hexanucleotide Repeat in Huntington-Like Patients: Systematic Review and Meta-Analysis.亨廷顿样患者中的六核苷酸重复序列:系统评价与荟萃分析
Front Genet. 2020 Nov 2;11:551780. doi: 10.3389/fgene.2020.551780. eCollection 2020.
3
Review of Hereditary and Acquired Rare Choreas.遗传性和获得性罕见舞蹈病综述。

本文引用的文献

1
The non-Huntington disease choreas: Five new things.非亨廷顿病性舞蹈症:五件新事。
Neurol Clin Pract. 2016 Apr;6(2):150-156. doi: 10.1212/CPJ.0000000000000236.
2
Erratum to "The analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism" [Neurobiol. Aging 36 (2015) 1221.e1-1221.e6].《对大量临床和病理诊断的非典型帕金森病病例中C9orf72重复扩增的分析》的勘误 [《神经生物学.衰老》36 (2015) 1221.e1 - 1221.e6]
Neurobiol Aging. 2015 Apr;36(4):1768. doi: 10.1016/j.neurobiolaging.2015.02.027. Epub 2015 Mar 19.
3
Hereditary chorea - what else to consider when the Huntington's disease genetics test is negative?
Tremor Other Hyperkinet Mov (N Y). 2020 Aug 6;10:24. doi: 10.5334/tohm.548.
4
Screening for the C9ORF72 expansion in Greek Huntington Disease phenocopies and controls and meta-analysis of current data.在希腊亨廷顿病表型模拟病例和对照中进行 C9ORF72 扩增的筛查,以及对现有数据的荟萃分析。
Tremor Other Hyperkinet Mov (N Y). 2020 Jun 12;10:5. doi: 10.5334/tohm.61.
5
Clinical Phenotype and Inheritance in Patients With C9ORF72 Hexanucleotide Repeat Expansion: Results From a Large French Cohort.C9ORF72六核苷酸重复扩增患者的临床表型与遗传特征:来自法国一个大型队列的研究结果
Front Neurosci. 2020 Apr 28;14:316. doi: 10.3389/fnins.2020.00316. eCollection 2020.
6
C9orf72 and its Relevance in Parkinsonism and Movement Disorders: A Comprehensive Review of the Literature.C9orf72及其在帕金森症和运动障碍中的相关性:文献综述
Mov Disord Clin Pract. 2018 Nov 8;5(6):575-585. doi: 10.1002/mdc3.12677. eCollection 2018 Nov-Dec.
遗传性舞蹈病——当亨廷顿舞蹈症基因检测呈阴性时还需考虑哪些因素?
Acta Neurol Scand. 2017 Jan;135(1):25-33. doi: 10.1111/ane.12609. Epub 2016 May 6.
4
C9ORF72 hexanucleotide repeat expansions are a frequent cause of Huntington disease phenocopies in the Greek population.C9ORF72六核苷酸重复扩增是希腊人群中亨廷顿病表型模拟的常见原因。
Neurobiol Aging. 2015 Jan;36(1):547.e13-6. doi: 10.1016/j.neurobiolaging.2014.08.020. Epub 2014 Aug 27.
5
C9orf72 expansion as a possible genetic cause of Huntington disease phenocopy syndrome.C9orf72基因扩增作为亨廷顿病表型模拟综合征的一种可能遗传病因。
J Neurol. 2014 Oct;261(10):1917-21. doi: 10.1007/s00415-014-7430-8. Epub 2014 Jul 18.
6
C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies.C9orf72 扩增是亨廷顿病表型模拟最常见的遗传原因。
Neurology. 2014 Jan 28;82(4):292-9. doi: 10.1212/WNL.0000000000000061. Epub 2013 Dec 20.
7
Huntington's disease and Huntington's disease-like syndromes: an overview.亨廷顿病和亨廷顿病样综合征:概述。
Curr Opin Neurol. 2013 Aug;26(4):420-7. doi: 10.1097/WCO.0b013e3283632d90.
8
Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records.基于普通诊所记录诊断的英国成人亨廷顿舞蹈病患病率。
J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1156-60. doi: 10.1136/jnnp-2012-304636. Epub 2013 Mar 12.
9
Huntington's disease phenocopy syndromes.亨廷顿病表型模拟综合征
Curr Opin Neurol. 2007 Dec;20(6):681-7. doi: 10.1097/WCO.0b013e3282f12074.
10
Huntington disease without CAG expansion: phenocopies or errors in assignment?无CAG重复序列扩增的亨廷顿病:表型模拟还是诊断错误?
Am J Hum Genet. 1994 May;54(5):852-63.